首页> 外文期刊>Free Radical Biology and Medicine: The Official Journal of the Oxygen Society >High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis
【24h】

High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis

机译:弥漫性皮肤系统性硬化症患者纤维化和非纤维化皮肤中的高活性氧

获取原文
获取原文并翻译 | 示例
           

摘要

Systemic sclerosis (SSc) is a chronic multisystemic connective tissue disease characterized by progressive fibrosis affecting skin and internal organs. Despite serious efforts to unveil the pathogenic mechanisms of 55c, they are still unclear. High levels of reactive oxygen species (ROS) in affected patients have been shown, and ROS are suggested to play a role in fibrosis pathogenesis. In this study we evaluate ROS levels in nonlibrotic and fibrotic skin of patients with SSc and we compare them with those obtained from healthy controls. We enrolled nine 5Sc patients fulfilling the EULAR/ACR classification criteria and seven healthy controls. Patients included four men and five women with mean age of 46 +/- 10 years. Controls were matched by sex and age. All patients were affected by the diffuse cutaneous form of SSc and the ANA pattern anti-Scl70. Mean disease duration was 7.5 +/- 5 years. Skin involvement was evaluated by modified Rodnan skin score. Skin samples (4-mm punch biopsy) were taken from fibrotic skin and nonfibrotic skin of patients and from healthy controls as well. To detect ROS, specimens were analyzed immediately after sampling by electron paramagnetic resonance spectroscopy. Blood samples were drawn from all patients and controls to assess oxidative stress biomarkers. ROS levels (expressed as median and range, in nmol/LIminimg of dry weight) were 24.7 (10.9-47.0) in fibrotic skin, 18.7 (7.3-34.0) in nonribrotic skin, and 7.7 (3.5-13.6) in healthy control skin. ROS levels in fibrotic and nonribrotic skin of SSc patients were significantly higher than in healthy controls (p =0.002 and p =0.009, respectively). ROS levels in fibrotic skin were raised in comparison to nonfibrotic skin, when samples related to each patient were compared (p=0.01). ROS levels in fibrotic skin were correlated with forced vital capacity (r- 0.75, p=0.02) and erythrocyte sedimentation rate (r=0.70, p=0.04), All other clinical and lab parameters showed no significant correlation. Compared to controls, blood from SSc patients showed lower ascorbate (vitamin C) levels (8 (3.8-9.8) vs 10.5 (9-19.1) ma, p-0004) and higher lipid peroxides (873.5 (342-1973) vs 422 (105-576) mu mol/L, p- 0.004). Our results indicate the presence of high oxidative stress in both nonfibrotic skin and fibrotic skin of SSc patients, but with higher tendency in the latter. Raised ROS levels in nonfibrotic skin of SSc patients might be a hint of early involvement in skin fibrogenesis. However, a longitudinal prospective study is necessary for such proof. (C) 2015 Elsevier Inc All rights reserved.
机译:系统性硬化症(SSc)是一种慢性多系统性结缔组织病,其特征是进行性纤维化会影响皮肤和内部器官。尽管为揭示55c的致病机理做了认真的努力,但它们仍不清楚。已经显示在受影响的患者中高水平的活性氧(ROS),并且建议ROS在纤维化发病机理中起作用。在这项研究中,我们评估了SSc患者非肝纤维化皮肤中的ROS水平,并将其与从健康对照中获得的水平进行了比较。我们招募了9名符合EULAR / ACR分类标准的5Sc患者和7名健康对照。患者包括四名男性和五名女性,平均年龄为46 +/- 10岁。对照按性别和年龄匹配。所有患者均受到SSc的弥漫性皮肤形式和ANA模式抗Scl70的影响。平均疾病持续时间为7.5 +/- 5年。通过改良的Rodnan皮肤评分评估皮肤受累情况。从患者的纤维化皮肤和非纤维化皮肤以及健康对照中采集皮肤样品(4毫米打孔活检)。为了检测ROS,样品在取样后立即通过电子顺磁共振波谱进行分析。从所有患者和对照中抽取血样,以评估氧化应激生物标志物。在纤维化皮肤中,ROS水平(以nmol / LIminimg表示为中值和范围,以干重计)为24.7(10.9-47.0),在非纤维化皮肤中为18.7(7.3-34.0),在健康对照皮肤中为7.7(3.5-13.6)。 SSc患者的纤维化和非纤维化皮肤中的ROS水平显着高于健康对照组(分别为p = 0.002和p​​ = 0.009)。当与每个患者相关的样本进行比较时,与非纤维化皮肤相比,纤维化皮肤中的ROS水平升高(p = 0.01)。纤维化皮肤中的ROS水平与强制肺活量(r-0.75,p = 0.02)和红细胞沉降率(r = 0.70,p = 0.04)相关,所有其他临床和实验室参数均无显着相关性。与对照组相比,SSc患者的血液显示出较低的抗坏血酸(维生素C)水平(8(3.8-9.8)对10.5(9-19.1)ma,p-0004)和较高的脂质过氧化物(873.5(342-1973)对422( 105-576)μmol/ L,p-0.004)。我们的结果表明SSc患者的非纤维化皮肤和纤维化皮肤均存在高氧化应激,但后者的趋势更高。 SSc患者非纤维化皮肤中的ROS水平升高可能是早期参与皮肤纤维化的提示。然而,纵向前瞻性研究对于这种证明是必要的。 (C)2015 Elsevier Inc保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号